< Back to news

FrieslandCampina and Glycosyn partner for new infant nutrition ingredients

February 11, 2016

John R. Garrett, co-CEO, at Glycosyn: “Human Milk Oligosaccharides (HMO’s) are specialised carbohydrates which are naturally prevalent in mother’s milk. Through our expertise and know-how we have developed technologies which will complement FrieslandCampina’s extensive history and knowledge of infant nutrition ingredients, products and markets.”

Tine Snels, Executive Director of FrieslandCampina Ingredients: “Glycosyn helps us to take a very exciting step towards developing the next generation of infant nutrition and to strengthen our position as a market leader in infant nutrition ingredients. We are doing this to meet the growing global demand for high-quality ingredients. Our cooperation is a perfect example of co-creation. The first quantities for trials will be available in the current year.”

FrieslandCampina Domo is part of FrieslandCampina Ingredients and a leading worldwide producer of a wide range of high-quality ingredients for the infant-, medical- and cell nutrition markets. Its range of products consists of whey protein concentrates, demineralised whey products, galacto-oligosaccharides, lactose, hydrolysates, encapsulated nutritional oils and the emerging products which are being developed from the Glycosyn partnership.

Glycosyn LLC: For more information: www.glycosynllc.com

Royal FrieslandCampina N.V.: For more information: www.frieslandcampina.com

FrieslandCampina Domo: For more information: www.domo.nl

For more information:

FrieslandCampina

Corporate Communication

Jan-Willem ter Avest

T + 31 (0)33 713 3885

avest@frieslandcampina.com